title: Two years of Provenge.
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods; D008297:Male; D009362:Neoplasm Metastasis / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000556:secondary* / Q000628:therapy*; D016019:Survival Analysis; D014020:Tissue Extracts / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014481:United States
chemical_list: D019496:Cancer Vaccines; D007155:Immunologic Factors; D014020:Tissue Extracts; C511774:sipuleucel-T